Radiation esophagitis is by many authors divided into two forms - acute and chronic [1] [2] [3] [4]. Acute radiation esophagitis is defined as the onset of esophageal-related symptoms as a response to radiation therapy (RT) within 3 weeks [1] [2] [3] [4]. Most commonly reported complaints are nausea, odynophagia, dysphagia, and anorexia that can promote significant weight loss [1] [2] [4]. Pain in the substernal region and discomfort is also seen in many patients, developing on the grounds of inflammatory changes occurring in the esophageal mucosa [1] [2]. The severity of the associated features strongly correlates with the radiation dose (more pronounced signs are seen with higher doses), a more advanced tumor stage, increased age, and the presence of adjuvant chemotherapy (bleomycin, vincristine, cyclophosphamide, actinomycin, and daunorubicin) [1] [2] [3] [5]. Some patients may not be able to swallow any food and thus require a feeding tube and/or total parenteral nutrition [2]. On the other hand, chronic radiation esophagitis occurs when at least three months pass from RT to the onset of the signs of the ailment, but the majority of patients report around 6-12 months [1] [2] [4]. The formation of esophageal strictures from fibrotic changes is the main factor for the development of symptoms in these patients, most important being progressive dysphagia, associated swallowing difficulties, and impaired mobility of the esophagus [1] [2].

The initial diagnosis of radiation esophagitis is made through a properly obtained patient history. Physicians must identify prior radiation therapy (implying that information about the underlying illness must also be collected) and a distinction between acute and chronic can be made based on the onset, course, and progression (as well as severity) of findings. The physical examination should focus on excluding oral candidiasis (through inspection of the oral cavity), recurrence of the primary disease (by palpating proximal lymph nodes) and aspiration pneumonia (through lung auscultation) [2]. Although the condition can be identified solely on clinical grounds, imaging studies should be employed to solidify suspicion [2]. Barium swallowing test is useful for detecting strictures and abnormal peristalsis, computed tomography (CT) is indicated for evaluation of disease recurrence and detection of a possible fistula, but endoscopy is regarded as the gold standard for esophageal assessment [1] [2]. In addition to strictures, typical findings on endoscopy include erosions, erythema, ulceration, and even hemorrhage, but the severity of esophageal damage may not always correlate with reported symptoms [1] [2]. Histology can be useful, particularly when opportunistic infections compromise the diagnosis, showing chronic inflammatory changes and extensive fibrosis [1] [2].

The primary goal of treating radiation esophagitis is to relieve symptoms and allow the esophagus to heal. Treatment options include dietary modifications, such as eating soft, bland foods and avoiding spicy or acidic items. Medications like antacids, proton pump inhibitors, and sucralfate can help reduce acid and protect the esophageal lining. In severe cases, pain management with analgesics or topical anesthetics may be necessary. Ensuring adequate nutrition and hydration is also crucial, and in some cases, a feeding tube may be required temporarily.

The prognosis for radiation esophagitis is generally favorable, as the condition often resolves after the completion of radiation therapy. Most patients experience significant improvement in symptoms within a few weeks to months. However, in some cases, long-term complications such as esophageal strictures (narrowing) can occur, requiring further intervention. Regular follow-up with healthcare providers is essential to monitor recovery and address any persistent issues.

Radiation esophagitis is caused by the exposure of the esophagus to radiation during cancer treatment. The radiation damages the cells lining the esophagus, leading to inflammation and irritation. The risk of developing this condition depends on factors such as the radiation dose, the treatment area, and the patient's overall health. Patients receiving concurrent chemotherapy may also have an increased risk due to the combined effects on the esophageal tissue.

Radiation esophagitis is a common side effect in patients undergoing radiation therapy for cancers in the chest region. The incidence varies depending on the type of cancer and the treatment regimen. It is estimated that up to 40% of patients receiving radiation for lung cancer may develop esophagitis. The condition is less common in patients treated for breast cancer, as the esophagus is less likely to be directly affected.

The pathophysiology of radiation esophagitis involves the direct damage to the esophageal mucosa by ionizing radiation. This damage triggers an inflammatory response, leading to swelling, ulceration, and pain. The radiation disrupts the normal cell turnover and repair processes, resulting in the breakdown of the protective lining of the esophagus. Over time, the inflammation can lead to fibrosis (scarring) and narrowing of the esophagus if not properly managed.

Preventing radiation esophagitis involves careful planning and management of radiation therapy. Techniques such as intensity-modulated radiation therapy (IMRT) can help minimize exposure to the esophagus by precisely targeting the tumor. Additionally, healthcare providers may recommend prophylactic measures, such as dietary adjustments and medications, to reduce the risk of developing esophagitis. Close monitoring during treatment allows for early intervention if symptoms begin to appear.

Radiation esophagitis is an inflammation of the esophagus caused by radiation therapy, commonly seen in patients treated for chest cancers. It presents with symptoms like difficulty swallowing and chest pain, which can significantly impact a patient's quality of life. Diagnosis involves clinical evaluation and imaging studies, while treatment focuses on symptom relief and nutritional support. With appropriate management, most patients recover well, although some may experience long-term complications.

If you are undergoing radiation therapy and experience symptoms such as difficulty swallowing, chest pain, or a burning sensation, you may have radiation esophagitis. This condition is a common side effect of radiation treatment for cancers in the chest area. It occurs because the radiation can irritate and inflame the esophagus. Treatment is available to help manage symptoms and support healing. It's important to communicate any symptoms to your healthcare team, who can provide guidance and support throughout your treatment.

1. Murro D, Jakate S. Radiation esophagitis. Arch Pathol Lab Med. 2015;139(6):827-830.
2. Baker S, Fairchild A. Radiation-induced esophagitis in lung cancer. Lung Cancer (Auckl). 2016;7:119-127.
3. Bar-Ad V, Ohri N, Werner-Wasik M. Esophagitis, treatment-related toxicity in non-small cell lung cancer. Rev Recent Clin Trials. 2012;7(1):31–35.4
4. Berkey FJ. Managing the adverse effects of radiation therapy. Am Fam Physician. 2010;82(4):381-388, 394.
5. Ahn S, Kahn D, Zhou S, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys. 2005;61(2):335–347.